Anti-inflammatory Therapy for Recurrent In-stent Restenosis

NCT06090890 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

252

Enrollment

OTHER

Sponsor class

Conditions

In-stent Restenosis

Interventions

DRUG: Colchicine
DRUG: Prednisone
DRUG: Aspirin
DRUG: P2Y12 Receptor Antagonist
DRUG: Lipid-lowering drug

Sponsor

Fu Wai Hospital, Beijing, China